From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. Neurology>
  4. Summary and Comment

High-Flow Oxygen for Cluster Headache

A randomized crossover trial finds this treatment effective.

Small placebo-controlled studies of high-flow oxygen in the treatment of cluster headache have suggested significant efficacy, but the treatment's efficacy has not been confirmed in a high-quality trial. Now, researchers have conducted a larger, partially manufacturer-sponsored, randomized, placebo-controlled, crossover trial of home use of high-flow oxygen delivered via mask. The authors randomized 109 adults with episodic or chronic cluster headache, previously naive to oxygen therapy, to treat four headache attacks acutely with either air or 100% oxygen at 12 L/minute using a nonrebreathing mask. The primary endpoint was freedom from pain at 15 minutes. Secondary endpoints were freedom from pain at 30 minutes; pain reduction at 15, 30, 45, and 60 minutes; need for rescue medications starting at 15 minutes; overall response to treatment; overall disability; and effect on associated symptoms.

The primary endpoint was reached significantly more often with oxygen (78% of attacks) than with air (20% of attacks). All the secondary endpoints were numerically in favor of oxygen.

Comment: This study provides documentation that oxygen is an effective treatment for cluster headache attacks. Injectable sumatriptan is approved by the FDA for this condition and is also highly effective. Some data support the use of sumatriptan, zolmitriptan, or dihydroergotamine nasal spray or high-dose zolmitriptan tablets. However, cost constraints make these treatments available only in small amounts, which is often insufficient to manage all the attacks. Furthermore, cluster headache is often comorbid with vascular disease (likely because of the high incidence of cigarette smoking in this population), and vascular disease contraindicates the use of triptans. However, the lack of portability of high-flow oxygen limits its usefulness. Individuals who smoke must be advised not to smoke in the vicinity of oxygen canisters.

— Mark W. Green, MD

Dr. Green is Professor of Neurology and Director of Headache and Pain Medicine, Mount Sinai School of Medicine, New York City.

Published in Journal Watch Neurology February 9, 2010

Citation(s):

Cohen AS et al. High-flow oxygen for treatment of cluster headache: A randomized trial. JAMA 2009 Dec 9; 302:2451.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

The editors of Journal Watch may respond to Reader Remarks, but we cannot promise to respond to a particular remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Sign-In

Forgot your password? Login via Athens
or your institution

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2010. Massachusetts Medical Society. All rights reserved.